Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pneumococcal lobar pneumonia treated with one injection of dibenzylethylenediamine dipenicillin G; a report of 49 cases.

Antibiotics & chemotherapy (Northfield, Ill.)·2014
Same author

A clinical study of four hundred patients with bronchial asthma.

Canadian Medical Association journal·2010
Same author

Jaundice present at birth.

The Medical clinics of North America·2010
Same author

A study of child health services.

Quarterly review of pediatrics·2010
Same author

Study I: Studies on Staphylococcus Pyogenes Aureus, Albus and Citreus, and on Micrococcus Tetragenus and M. Catarrhalis.

The Journal of medical research·2009
Same author

Study II: Studies of a Diphtheroid Organism isolated from the Sputum of Patients with bronchial Asthma.

The Journal of medical research·2009
Same journal

Retraction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.

The Journal of experimental medicine·2026
Same journal

Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.

The Journal of experimental medicine·2026
Same journal

Flawed translation triggers oncogenic B-T cell communication.

The Journal of experimental medicine·2026
Same journal

Correction: LCK'ed in: Inborn errors of immunity in LCK reveal how TCR signaling is calibrated.

The Journal of experimental medicine·2026
Same journal

Mechanobiology of inflammation: Pulling the strings of innate immunity.

The Journal of experimental medicine·2026
Same journal

Bile acid retention in efferocytic macrophages shapes their inflammatory status during cholangitis.

The Journal of experimental medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 19, 2026

Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

EXPERIMENTAL PNEUMONIA (FRIEDLANDER TYPE).

W R Sisson1, I C Walker

  • 1Departments of Medicine and Pathology of the Harvard Medical School and the Peter Bent Brigham Hospital, Boston.

The Journal of Experimental Medicine
|October 30, 2009
PubMed
Summary
This summary is machine-generated.

Bacillus mucosus capsulatus causes lobar pneumonia in cats, differing from pneumococcal types. This experimental pneumonia resembles Friedländer's bacillus in humans, with varied pathological findings and a short, toxemic course.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
07:43

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice

Published on: September 28, 2016

Related Experiment Videos

Last Updated: Jun 19, 2026

Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
07:43

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice

Published on: September 28, 2016

Area of Science:

  • Veterinary Pathology
  • Infectious Diseases
  • Bacteriology

Background:

  • Lobar pneumonia is a significant respiratory illness.
  • The role of specific bacterial agents in pneumonia pathogenesis requires ongoing investigation.
  • Experimental models are crucial for understanding disease mechanisms.

Purpose of the Study:

  • To investigate the causation of lobar pneumonia in cats using Bacillus mucosus capsulatus.
  • To characterize the clinical and pathological features of this experimental pneumonia.
  • To compare the induced pneumonia with known human pneumonia types.

Main Methods:

  • Intrabronchial insufflation and intravenous injection of Bacillus mucosus capsulatus in cats.
  • Clinical observation of disease progression and symptoms.
  • Macroscopic and microscopic examination of lung tissues.
  • Bacteriological analysis of lung tissue and blood cultures.

Main Results:

  • Bacillus mucosus capsulatus successfully induced lobar pneumonia in cats.
  • The induced pneumonia exhibited a short, toxemic course, distinct from pneumococcal pneumonia.
  • Pathological findings included variable consolidation, hemorrhage, and significant polymorphonuclear cell infiltration.
  • Large vacuolated mononuclear cells, potentially of epithelial origin, were prominent phagocytes.
  • Positive blood cultures were obtained in 87% of affected animals.

Conclusions:

  • Bacillus mucosus capsulatus is a causative agent of lobar pneumonia in cats.
  • This experimental model offers insights into pneumonia pathogenesis, potentially supporting hematogenous spread.
  • The findings suggest similarities to Friedländer's bacillus pneumonia in humans.
  • Further research is needed to elucidate the precise pathological sequence and etiological theories.